Erik Slinger

656 total citations
8 papers, 501 citations indexed

About

Erik Slinger is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Erik Slinger has authored 8 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Erik Slinger's work include Cytomegalovirus and herpesvirus research (4 papers), Viral-associated cancers and disorders (2 papers) and Immunotherapy and Immune Responses (2 papers). Erik Slinger is often cited by papers focused on Cytomegalovirus and herpesvirus research (4 papers), Viral-associated cancers and disorders (2 papers) and Immunotherapy and Immune Responses (2 papers). Erik Slinger collaborates with scholars based in Netherlands, United States and Sweden. Erik Slinger's co-authors include Martine J. Smit, David Maussang, Marco Siderius, Andreas Schreiber, Sérgio A. Lira, Cecilia Söderberg‐Nauclér, Afsar Rahbar, Ellen Langemeijer, Alberto Fraile‐Ramos and Rob Leurs and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Erik Slinger

8 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Slinger Netherlands 8 325 215 147 79 35 8 501
Andrea L. Volk United States 6 246 0.8× 86 0.4× 152 1.0× 91 1.2× 30 0.9× 7 396
Christoph Rohde Germany 7 162 0.5× 143 0.7× 149 1.0× 106 1.3× 121 3.5× 8 587
Andrea Cortini United Kingdom 10 126 0.4× 321 1.5× 55 0.4× 176 2.2× 13 0.4× 12 524
Duane A. Mitchell United States 2 208 0.6× 144 0.7× 116 0.8× 61 0.8× 27 0.8× 4 337
Nicole L. Glosson United States 9 121 0.4× 258 1.2× 61 0.4× 109 1.4× 19 0.5× 12 434
T Sobande United Kingdom 6 90 0.3× 326 1.5× 49 0.3× 45 0.6× 16 0.5× 9 459
Petra Skarman Sweden 6 138 0.4× 160 0.7× 74 0.5× 66 0.8× 17 0.5× 6 339
J. Philip Nance United States 9 77 0.2× 336 1.6× 74 0.5× 84 1.1× 99 2.8× 10 504
Magdalena Hagn Australia 11 57 0.2× 560 2.6× 182 1.2× 94 1.2× 8 0.2× 13 697
Branka Popović Croatia 10 98 0.3× 338 1.6× 105 0.7× 94 1.2× 18 0.5× 18 435

Countries citing papers authored by Erik Slinger

Since Specialization
Citations

This map shows the geographic impact of Erik Slinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Slinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Slinger more than expected).

Fields of papers citing papers by Erik Slinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Slinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Slinger. The network helps show where Erik Slinger may publish in the future.

Co-authorship network of co-authors of Erik Slinger

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Slinger. A scholar is included among the top collaborators of Erik Slinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Slinger. Erik Slinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kavazović, Inga, Hongya Han, Erik Slinger, et al.. (2020). Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. PLoS Biology. 18(3). e3000648–e3000648. 34 indexed citations
2.
Senten, Jeffrey R. van, Maarten P. Bebelman, Raimond Heukers, et al.. (2019). The human cytomegalovirus-encoded G protein–coupled receptor UL33 exhibits oncomodulatory properties. Journal of Biological Chemistry. 294(44). 16297–16308. 23 indexed citations
3.
Chen, Lili, Zhengxiang He, Erik Slinger, et al.. (2014). IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. Mucosal Immunology. 8(2). 390–402. 47 indexed citations
4.
Bongers, Gerold, Luciana R. Muniz, Alina C. Iuga, et al.. (2012). A Role for the Epidermal Growth Factor Receptor Signaling in Development of Intestinal Serrated Polyps in Mice and Humans. Gastroenterology. 143(3). 730–740. 30 indexed citations
5.
Langemeijer, Ellen, Erik Slinger, Andreas Schreiber, et al.. (2012). Constitutive ß-Catenin Signaling by the Viral Chemokine Receptor US28. PLoS ONE. 7(11). e48935–e48935. 34 indexed citations
6.
Slinger, Erik, Ellen Langemeijer, Marco Siderius, Henry F. Vischer, & Martine J. Smit. (2010). Herpesvirus-encoded GPCRs rewire cellular signaling. Molecular and Cellular Endocrinology. 331(2). 179–184. 27 indexed citations
7.
Slinger, Erik, David Maussang, Andreas Schreiber, et al.. (2010). HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis. Science Signaling. 3(133). ra58–ra58. 178 indexed citations
8.
Maussang, David, Ellen Langemeijer, Carlos P. Fitzsimons, et al.. (2009). The Human Cytomegalovirus–Encoded Chemokine Receptor US28 Promotes Angiogenesis and Tumor Formation via Cyclooxygenase-2. Cancer Research. 69(7). 2861–2869. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026